"The completion of our critical study for LAVERDIA®-CA1 marks a major milestone in bringing forward an innovative therapy for canine lymphoma", said Dylan Balsz, CEO of Anivive. "We are excited ...

Clinical trial sites across nine states have closed for one of the largest canine lymphoma studies Effectiveness data will soon be finalized for statistical review and FDA submission LONG BEACH ...

Cancer remains a leading cause of death in canines, with 1 in 4 dogs in the U.S. expected to be diagnosed with cancer in their lifetime. 2 Lymphoma, one of the most common cancers in dogs ...

Feb. 14, 2025 /PRNewswire/ -- Anivive, a software-driven pet health company, today announced the successful completion of its pivotal field study evaluating the safety and effectiveness of ...

Canine lymphoma, particularly diffuse large B-cell lymphoma (DLBCL), is a significant health concern in dogs, characterized by its aggressive nature and varied clinical outcomes. Recent research ...

IDEXX Laboratories, Inc., a global leader in pet healthcare innovation, announced the launch of IDEXX Cancer Dx, a first-of-its-kind diagnostic panel with early detection of lymphoma in dogs, ...

This animal, from before the age of the dinosaurs, was a dog-like creature that was ... Dogs Trained to Sniff out Spotted Lanternflies Could Help Reduce Spread Jan. 2, 2025 — Growers and ...

Such may be the human condition. But as anyone who’s ever owned a dog will tell you, it’s not a problem—or a regret—that dogs seem to have. In their boundless joys and wild anxieties alike ...

There are plenty of strategies to train your dog, but is there a particularly effective method to get your pet pal to pay attention to you? A team of scientists believes the most successful ...